Form 4: Crexendo Director Chris McKee Granted Stock Options

Crexendo, Inc. Director Chris McKee was granted 10,000 stock options with an exercise price of $6.47, vesting monthly over three years.

Summary

• Chris McKee, a Director of Crexendo, Inc. (CXDO), acquired 10,000 stock options.
• The transaction date for the option grant was March 4, 2026.
• The exercise price for these stock options is $6.47 per share.
• The options will vest in 36 equal monthly installments, commencing on April 4, 2026.
• The expiration date for these stock options is March 4, 2036.
• Following this transaction, Chris McKee beneficially owns 10,000 derivative securities directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it aligns the director's financial incentives with the long-term performance of Crexendo, Inc., which is generally beneficial for shareholders.

Positives

• The grant of stock options to a director aligns their financial interests with the long-term performance and shareholder value of Crexendo, Inc.
• This is a standard compensation practice that incentivizes management to work towards increasing the company's stock price.

Future Outlook

The grant of stock options to Director Chris McKee suggests an incentive structure designed to encourage long-term commitment and performance, aligning his future financial gains with the company's stock appreciation over the next decade.

Industry Context

StockSavvy.ai notes that stock option grants are a common form of executive and director compensation across industries, designed to align long-term interests with shareholder value by providing a direct financial incentive for the recipient to contribute to the company's growth and stock price appreciation.

Stakeholder Impact

• Shareholders: Potential positive impact as the director's interests are further aligned with increasing shareholder value through stock price appreciation.

Next Steps

• The stock options will vest over 36 equal monthly installments beginning April 4, 2026.

Key Dates

Recommendation

This Form 4 reports a routine grant of stock options to a director, which is a standard compensation practice. It does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. Investors should continue to monitor the company's broader financial performance and strategic initiatives.

Keywords

Crexendo, CXDO, Chris McKee, stock options, insider transaction, Form 4, director compensation, equity grant